@article{3a20b726c1d34ec799db8463dda903a3,
title = "A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma",
abstract = "Molecular",
keywords = "biotechnology, cancer systems biology, genetics, molecular physiology",
author = "Erdem Bangi and Peter Smibert and Uzilov, {Andrew V.} and Teague, {Alexander G.} and Sindhura Gopinath and Yevgeniy Antipin and Rong Chen and Chana Hecht and Nelson Gruszczynski and Yon, {Wesley J.} and Denis Malyshev and Denise Laspina and Isaiah Selkridge and Huan Wang and Jorge Gomez and John Mascarenhas and Moe, {Aye S.} and Lau, {Chun Yee} and Patricia Taik and Chetanya Pandya and Max Sung and Sara Kim and Kendra Yum and Robert Sebra and Michael Donovan and Krzysztof Misiukiewicz and Celina Ang and Schadt, {Eric E.} and Posner, {Marshall R.} and Cagan, {Ross L.}",
note = "Funding Information: We thank the Cagan Laboratory for important discussions and the Genomics Core Facility at the Icahn Institute and Department of Genetics and Genomic Sciences for providing technical support. Computational help and resources were provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai. A patent application has been filed that is related to this work. This work was supported by funds from the Dean{\textquoteright}s Office and by NIH - U54OD020353 . Funding Information: We thank the Cagan Laboratory for important discussions and the Genomics Core Facility at the Icahn Institute and Department of Genetics and Genomic Sciences for providing technical support. Computational help and resources were provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai. A patent application has been filed that is related to this work. This work was supported by funds from the Dean's Office and by NIH-U54OD020353. Conceptualization: E.B. P.S. K.M. M.P. R.L.C.; Investigation: E.B. P.S. A.U. N.G. A.S.M. A.T. S.G. Y.A. C.H. N.A. C.P. W.Y. D.M. D.L. I.S. C.Y.L. R.S. P.T. M.D.; Formal Analysis including Tumor Board: E.B. J.M. A.U. R.C. A.S.M. H.W. J.G. C.P. M.S. S.K. K.Y. R.S. M.D. K.M. C.A. E.S. M.P. R.L.C.; Writing: E.B. M.P. A.U. H.W. R.L.C.; Project Administration: E.B. I.S. E.S. K.M. M.P. R.L.C.; Funding Acquisition: E.S. R.L.C. E.B. and R.L.C. are named inventors on patents related to the use of Drosophila to develop cancer treatments including a licensing interest in My Personal Therapeutics. R.L.C. reports being a member of My Personal Therapeutics' advisory board. Publisher Copyright: {\textcopyright} 2021 The Authors",
year = "2021",
month = mar,
day = "19",
doi = "10.1016/j.isci.2021.102212",
language = "English",
volume = "24",
journal = "iScience",
issn = "2589-0042",
publisher = "Elsevier Inc.",
number = "3",
}